In low- to middle-income countries, SGLT2 inhibitors could reduce diabetes complications at lower but feasible prices; they are cost effective at current prices in people with heart or kidney disease.
Dr Mohan s Diabetes Conducts the 6th Edition of International Diabetes Update in Chennai – Chennaionline chennaionline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chennaionline.com Daily Mail and Mail on Sunday newspapers.